C4 Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in C4 Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $189k | 72k | 2.64 |
| 2025-12-31 | $24k | 12k | 1.94 |
| 2025-09-30 | $28k | 12k | 2.26 |
| 2025-06-30 | $18k | 12k | 1.45 |
| 2025-03-31 | $62k | 38k | 1.63 |
| 2024-12-31 | $138k | 38k | 3.62 |
| 2024-09-30 | $2.2M | 392k | 5.70 |
| 2024-06-30 | $288k | 62k | 4.62 |
| 2024-03-31 | $17M | 2.1M | 8.17 |
| 2023-12-31 | $15M | 2.6M | 5.65 |
| 2023-09-30 | $4.1M | 2.2M | 1.86 |
| 2023-06-30 | $7.8M | 2.8M | 2.75 |
| 2023-03-31 | $9.0M | 2.9M | 3.14 |
| 2022-12-31 | $17M | 2.9M | 5.90 |
| 2022-03-31 | $106M | 4.4M | 24.26 |
| 2021-12-31 | $132M | 4.1M | 32.20 |
| 2021-09-30 | $177M | 4.0M | 44.68 |
| 2021-06-30 | $134M | 3.5M | 37.84 |
| 2021-03-31 | $78M | 2.1M | 36.99 |
| 2020-12-31 | $49M | 1.5M | 32.27 |